Virtus ETF Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Virtus ETF Advisers's ABBV Position: Q3 2026 in Review
Virtus ETF Advisers reduced its AbbVie (ABBV) stake by 4.2% in Q3 2026, selling an estimated $11.3K and leaving 1,012 shares worth $265K. The position accounts for 0.1% of the portfolio, ranked #248.
Virtus ETF Advisers first reported a position in ABBV in Q4 2019 and has held it in 14 quarters since. The position peaked at $952K in Q1 2023. 4,255 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Virtus ETF Advisers held 1,012 shares of AbbVie worth $265K as of Q3 2026.
- Virtus ETF Advisers sold 44 AbbVie shares in Q3 2026, an estimated $11.3K.
- AbbVie made up 0.1% of Virtus ETF Advisers's portfolio in Q3 2026, its #248 holding.
- Virtus ETF Advisers first reported a position in AbbVie in Q4 2019 and has held it in 14 quarters since.
- Virtus ETF Advisers's AbbVie position peaked at $952K in Q1 2023.
- 4,255 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.